Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT03838263 |
Title | Feasibility and Tolerance of Nivolumab Neoadjuvant Immunotherapy in High Risk HPV Driven Oropharynx Cancer (IMMUNEBOOST) |
Acronym | IMMUNEBOOST |
Recruitment | Active, not recruiting |
Gender | both |
Phase | Phase II |
Variant Requirements | Yes |
Sponsors | UNICANCER |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | FRA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Institut Sainte Catherine | Avignon | 84918 | France | Details | ||
Hopital Beaujon | Clichy | 92100 | France | Details | ||
Centre Léon Bérard | Lyon | 69373 | France | Details | ||
Centre Antoine Lacassagne | Nice | 06189 | France | Details | ||
Institut Curie | Paris | 75005 | France | Details | ||
Hopital Europeen Georges Pompidou | Paris | 75015 | France | Details | ||
Hopital Tenon | Paris | 75970 | France | Details | ||
Centre Henri Becquerel | Rouen | 76038 | France | Details | ||
Hopital Foch | Suresnes | 92150 | France | Details | ||
Institut de cancerologie de Lorraine Alexis Vautrin | Vandoeuvre-Les-Nancy | 54519 | France | Details | ||
Institut Gustave Roussy | Villejuif | 94805 | France | Details |